Pamela Celis – Laborant – Molekylær Medicinsk Adeling | LinkedIn
InfiniteBody: 12/1/18 - 1/1/19
Student Life - Columbia College - Columbia University
Pamela Celis – Laborant – Molekylær Medicinsk Adeling | LinkedIn
Pamela Celis – Laborant – Molekylær Medicinsk Adeling | LinkedIn
IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Pamela Celis – Laborant – Molekylær Medicinsk Adeling | LinkedIn
SAM Gallery Archives - SAMBlog
Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome | Scientific Reports
IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer | PLOS ONE
DCD Bulletin May 2021 by Leslie Bowen - Issuu
Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer | PLOS ONE
Staff
Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells | British Journal of Cancer
IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
OPRA (SomaSeq)
Pamela Celis – Laborant – Molekylær Medicinsk Adeling | LinkedIn
Palm Beach Illustrated January 2018 by Palm Beach Media Group - Issuu
art&culture winter 2018 by Palm Beach Media Group - Issuu
GENLUX - JENNIFER MCMANIS by GENLUX - Issuu
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy - Strand - 2019 - International Journal of Cancer - Wiley Online Library
2009 Annual Listing
SAM Gallery Archives - SAMBlog
OPRA (SomaSeq)
